Skip to main content

FDA recall, , Moderate risk

The Blood Center Red Blood Cells, Leukocytes Reduced

Red Blood Cells, Leukocytes Reduced were incorrectly labeled as irradiated and distributed.

Recall ended Sep 21, 2026. Still check yours.

What happened

The Blood Center is recalling Red Blood Cells, Leukocytes Reduced because the units were incorrectly labeled as irradiated and distributed. The recall involves 38 units and was initiated on July 10, 2025, in Louisiana. The FDA added the recall to its Enforcement Report on September 21, 2026, and it was included in the weekly enforcement report on September 30, 2026.

What to do

We don't have product-specific instructions for this recall. FDA's general advice for medicine recalls:

  1. Check the FDA or company notice for instructions specific to this product.
  2. Ask your pharmacist or doctor whether your lot is affected and what to do.

Is yours affected?

Compare these details with yours, then check the recall notice to see which units are recalled.

  1. Red Blood Cells, Leukocytes Reduced

Recall details

Company began the recall
Company
The Blood Center
Risk

Moderate risk

Taking it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.

FDA Class II recall · How risk is rated

Event ID
98875
Recall number
B-0202-2026
Quantity recalled
38 units

All recalls from The Blood Center

Timeline

FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.

  1. Company began the recall

  2. Added to FDA's Enforcement Report · Classified by FDA · Recall ended

  3. In FDA's weekly enforcement report

  4. Listed on Recall Canary

Summary by Recall Canary, written with AI · summary updated Oct 23, 2026 · primary source: U.S. Food and Drug Administration (opens in a new tab)